Sort
23,748 grants matching “melanoma”
Development of Novel Inhibitors of Ganglioside Biosynthesis
$106,461Brett E Crawford · Zacharon Pharmaceuticals, Inc. · R44 · FY2010 · CA
TUMOR VACCINES FOR THE TREATMENT OF ORAL MELANOMA
$106,404University Of Wisconsin Madison · R01 · FY2000 · DE
Chromatin Remodeling in UVR Induced Melanogenesis
$106,400University Of Toledo Health Sci Campus · K22 · FY2005 · ES
Mechanisms of Intrinsic Host Responses to Hantavirus Infection
$106,320Alison Kell · University Of New Mexico Health Scis Ctr · K22 · FY2021 · AI
Multicolor Rainbow imaging of Clonal Expansion in Tumors
$106,225Charles P Lin · Massachusetts General Hospital · P50 · FY2015 · CA
The role of CD4+ T cells in melanoma immunotherapy
$106,205University Of Virginia Charlottesville · K01 · FY2002 · CA
Moffitt Cancer Center Support Grant
$106,110Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2013 · CA
Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and Progression
$106,110Timothy Louis Frankel · University Of Michigan At Ann Arbor · K08 · FY2017 · CA
Targeting NRAS posttranslational modifications for melanoma treatment
$106,014Chengqian Yin · Massachusetts General Hospital · K99 · FY2020 · CA
Developmental Research Program (DRP)
$105,948David F Stern · Yale University · P50 · FY2025 · CA
Career Enhancement Program (CEP)
$105,947David F Stern · Yale University · P50 · FY2025 · CA
Project 3: Prognostic and Functional Role of a Gene Expression Signature in Melanoma Patients
$105,854Eva Hernando · University Of New Mexico Health Scis Ctr · P01 · FY2020 · CA
Molecular Interactions During Neural Crest Formation
$105,771Martin Ignacio Garcia-Castro · University Of California Riverside · R01 · FY2017 · DE
RETINOID RECEPTOR FUNCTION IN SKIN CANCER PROGRESSION
$105,700University Of Texas Md Anderson Can Ctr · R29 · FY2001 · CA
RETINOID RECEPTOR FUNCTION IN SKIN CANCER PROGRESSION
$105,700University Of Texas Md Anderson Can Ctr · R29 · FY2000 · CA
CORE--MICROSCOPIC IMAGING
$105,657University Of Texas Sw Med Ctr/Dallas · R24 · FY2005 · EY
SOUTHWEST ONCOLOGY GROUP
$105,648Oregon Health And Science University · U10 · FY2003 · CA
Cancer and Leukemia Group B
$105,577University Of North Carolina Chapel Hill · U10 · FY2003 · CA
Experimental Pathology
$105,571Cynthia A Loomis · New York University School Of Medicine · P30 · FY2008 · CA
Novel 125I Uniformly Distributed Ophthalmic Plaques
$105,526Implant Sciences Corporation · R43 · FY2001 · CA
Anti-melanoma Activity of Combined Lymphopenia and Immunotherapy
$105,494Shari Pilon-Thomas · H. Lee Moffitt Cancer Ctr & Res Inst · K99 · FY2008 · CA
Lipid programs in melanocyte transformation
$105,482Michael H. Overholtzer · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Chromatin Remodeling in UVR Induced Melanogenesis
$105,463Ivana L De La Serna · University Of Toledo Health Sci Campus · K22 · FY2007 · ES
Chromatin Remodeling in UVR Induced Melanogenesis
$105,463Ivana L De La Serna · University Of Toledo Health Sci Campus · K22 · FY2006 · ES
Core B: Pathology Core
$105,285Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA